Kenneth C. Cundy

SVP, Preclinical Development, XENOPORT INC.

Companies

Anebulo Pharmaceuticals, Inc.Chief Scientific Officer May 24, 2022 to Apr 7, 2025¹
CohBar, Inc.Chief Scientific Officer Dec 19, 2014 to Aug 13, 2021²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAnebulo Pharmaceuticals, Inc., Chief Scientific Officer
2
SEC EDGARCohBar, Inc., Chief Scientific Officer